{
      "brief_title": [
            "study",
            "evaluate",
            "lymphoma"
      ],
      "brief_summary": [
            "determine",
            "maximum",
            "tolerate",
            "dose",
            "mtd",
            "tolerability",
            "initial",
            "safety",
            "profile",
            "subject",
            "lymphoma",
            "nhl"
      ],
      "condition": [],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Inotuzumab ozogamicin [CMC-544]"
      ],
      "description": [
            "iv",
            "dose",
            "escalation",
            "trial"
      ],
      "arm_group_label": [
            "ozogamicin"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "subject",
            "previously",
            "diagnose",
            "nhl",
            "accord",
            "classification",
            "progress",
            "least",
            "2",
            "prior",
            "therapy",
            "probable",
            "clinical",
            "benefit",
            "expand",
            "cohort",
            "part",
            "2",
            "study",
            "subject",
            "must",
            "one",
            "follow",
            "follicular",
            "lymphoma",
            "previously",
            "treat",
            "least",
            "one",
            "dose",
            "rituximab",
            "receive",
            "radioimmunotherapy",
            "diffuse",
            "large",
            "lymphoma",
            "age",
            "18",
            "year",
            "older",
            "exclusion",
            "criterion",
            "candidate",
            "potentially",
            "curative",
            "therapy",
            "opinion",
            "investigator",
            "chronic",
            "lymphocytic",
            "leukemia",
            "burkitt",
            "lymphoma",
            "primary",
            "effusion",
            "lymphoma",
            "precursor",
            "lymphoblastic",
            "lymphoma"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "lymphoma"
      ],
      "mesh_term": [],
      "id": "NCT00073749"
}